165 related articles for article (PubMed ID: 32496052)
1. pH-Responsive Biomimetic Polymeric Micelles as Lymph Node-Targeting Vaccines for Enhanced Antitumor Immune Responses.
Yang X; Yu T; Zeng Y; Lian K; Zhou X; Ke J; Li Y; Yuan H; Hu F
Biomacromolecules; 2020 Jul; 21(7):2818-2828. PubMed ID: 32496052
[TBL] [Abstract][Full Text] [Related]
2. Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity.
Yang X; Lian K; Meng T; Liu X; Miao J; Tan Y; Yuan H; Hu F
ACS Appl Mater Interfaces; 2018 Oct; 10(39):33532-33544. PubMed ID: 30192498
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses.
Li C; Zhang X; Chen Q; Zhang J; Li W; Hu H; Zhao X; Qiao M; Chen D
ACS Appl Mater Interfaces; 2018 Jan; 10(3):2874-2889. PubMed ID: 29285934
[TBL] [Abstract][Full Text] [Related]
4. Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy.
Yang X; Yu T; Zeng Y; Lian K; Zhou X; Li S; Qiu G; Jin X; Yuan H; Hu F
Carbohydr Polym; 2020 Jul; 240():116270. PubMed ID: 32475559
[TBL] [Abstract][Full Text] [Related]
5. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
[TBL] [Abstract][Full Text] [Related]
6. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
[TBL] [Abstract][Full Text] [Related]
7. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
[TBL] [Abstract][Full Text] [Related]
8. Construction of lymph nodes-targeting tumor vaccines by using the principle of DNA base complementary pairing to enhance anti-tumor cellular immune response.
Zha Y; Fu L; Liu Z; Lin J; Huang L
J Nanobiotechnology; 2024 May; 22(1):230. PubMed ID: 38720322
[TBL] [Abstract][Full Text] [Related]
9. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
[TBL] [Abstract][Full Text] [Related]
10. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
[TBL] [Abstract][Full Text] [Related]
11. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S
J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066
[TBL] [Abstract][Full Text] [Related]
12. Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity.
Kim SY; Noh YW; Kang TH; Kim JE; Kim S; Um SH; Oh DB; Park YM; Lim YT
Biomaterials; 2017 Jun; 130():56-66. PubMed ID: 28364631
[TBL] [Abstract][Full Text] [Related]
13. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy.
Su Q; Liu Z; Du R; Chen X; Chen L; Fu Z; Luo X; Yang Y; Shi X
Acta Biomater; 2023 Mar; 158():510-524. PubMed ID: 36603733
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
15. Self-adjuvanted L-arginine-modified dextran-based nanogels for sustained local antigenic protein delivery to antigen-presenting cells and enhanced cellular and humoral immune responses.
Chung JT; Rafiei M; Chau Y
Biomater Sci; 2024 Mar; 12(7):1771-1787. PubMed ID: 38385306
[TBL] [Abstract][Full Text] [Related]
16. Cryogel vaccines effectively induce immune responses independent of proximity to the draining lymph nodes.
Najibi AJ; Shih TY; Mooney DJ
Biomaterials; 2022 Feb; 281():121329. PubMed ID: 34954588
[TBL] [Abstract][Full Text] [Related]
17. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
18. Delivered antigen peptides to resident CD8α
Wang L; Wang Z; Qin Y; Liang W
Eur J Pharm Biopharm; 2020 Feb; 147():76-86. PubMed ID: 31887349
[TBL] [Abstract][Full Text] [Related]
19. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.
Zhang C; Shi G; Zhang J; Song H; Niu J; Shi S; Huang P; Wang Y; Wang W; Li C; Kong D
J Control Release; 2017 Jun; 256():170-181. PubMed ID: 28414151
[TBL] [Abstract][Full Text] [Related]
20. Anti-CTLA-4 antibody-functionalized dendritic cell-derived exosomes targeting tumor-draining lymph nodes for effective induction of antitumor T-cell responses.
Phung CD; Pham TT; Nguyen HT; Nguyen TT; Ou W; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2020 Oct; 115():371-382. PubMed ID: 32798721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
